CVS Health Corp. diskutieren
CVS Health Corp.
WKN: 859034 / Symbol: CVS / Name: CVS Health / Aktie / Lebensmittel- & Medikamentenhandel / Large Cap /
52,11 €
0,27 %
Loading data...
Buy CVS Health Corp.
Sell CVS Health Corp.
Buy CVS Health Corp.
Sell CVS Health Corp.
Buy CVS Health Corp.
.png?locale=de "FinanceClub_UoM")
Buy CVS Health Corp.
CVS Health Co. (NYSE: CVS) had its price target lowered by analysts at Bank of America Co. from $111.00 to $104.00. They now have a "buy" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its price target lowered by analysts at Royal Bank of Canada from $102.00 to $91.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its price target lowered by analysts at Morgan Stanley from $120.00 to $110.00. They now have an "overweight" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its price target lowered by analysts at Raymond James from $90.00 to $85.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $91.00 price target on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $80.00 price target on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $87.00 price target on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $83.00 price target on the stock, up previously from $81.00.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $87.00 price target on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its price target lowered by analysts at TD Cowen from $102.00 to $99.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) is now covered by analysts at HSBC Holdings plc. They set a "buy" rating and a $94.00 price target on the stock.
Ratings data for CVS provided by MarketBeat
CVS Health Co. (NYSE: CVS) had its price target lowered by analysts at Royal Bank of Canada from $86.00 to $84.00. They now have an "outperform" rating on the stock.
Ratings data for CVS provided by MarketBeat
Neueste Beiträge
National_Bankshares_ in Brookfield Asset Management Inc. diskutieren, Brookfield Corp.